- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01505374
Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty
Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: A Comparative Effectiveness Study in Bilateral Total Knee Arthroplasty Patients
Currently, the regional anesthetic standard of care for total knee replacement surgery is combined spinal/epidural to provide long-lasting pain relief with or without a femoral nerve block (FNB). The femoral nerve block refers to a technique that your anesthesiologist can use to numb the thigh muscle for approximately 18 hours after surgery. While this technique offers significant pain relief, it is possible it may cause muscle weakness and increase patients' recovery times. Hence there is a need for an alterative anesthetic technique, one that may help minimize postoperative pain as effectively as a femoral nerve block, while not causing weakness of the thigh muscle.
The saphenous nerve, a branch of the femoral nerve, provides sensation to the knee. Thus it is hypothesized by "blocking" or anesthetizing the saphenous nerve with local anesthetic closer to where it branches off, the area around and below the knee will feel numb. Yet unlike the femoral nerve block, the thigh muscle itself will still be able to function.
For patients undergoing two total knee replacements at one time or bilateral total knee replacement, they will be randomly assigned to receive a femoral nerve block on one leg and a saphenous block on the other. Pain levels will be measured and thigh muscle strength will be tested using a dynamometer before surgery, 6-8 hours following anesthesia administration, and on postoperative days 1 and 2.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Hospital for Special Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients ages 40-80 undergoing Bilateral Total Knee Replacement
- Planned use of neuraxial anesthesia
- Ability to follow study protocol
Exclusion Criteria:
- Contraindication to a spinal or epidural anesthestic
- Not a candidate for bilateral total knee replacement
- Chronic opioid use (defined as daily or almost daily use of opioids for >3 months)
- Hypersensitivity and/or allergy to local anesthetics
- Intraoperative use of any volatile anesthetic
- Patients with pre-existing neuropathy on the operative limb
- Contraindication to femoral nerve block or saphenous nerve block
- Allergy to any of the study medications
- American Society of Anesthesiologists (ASA) Class 4-5
- Non-English speaking patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Study Technique Left Leg, Control Technique Right Leg
|
One leg will receive the saphenous nerve block, at the level of the adductor canal (study technique).
The block will be under ultrasound guidance.
The local anesthetic will be 15 ml of 0.5% bupivacaine.
All study patients, regardless of study arm will receive combined spinal epidural, with 3 ml of 0.5% bupivacaine as the spinal agent.
Epidural local anesthetic, if needed, will consist of 2% lidocaine.
The other leg will receive the femoral nerve block (control technique).
The block will be under ultrasound guidance.
The local anesthetic will be 30 ml of 0.25% bupivacaine.
All study patients, regardless of study arm will receive combined spinal epidural, with 3 ml of 0.5% bupivacaine as the spinal agent.
Epidural local anesthetic, if needed, will consist of 2% lidocaine.
|
|
EXPERIMENTAL: Study Technique Right Leg, Control Technique Left Leg
|
One leg will receive the saphenous nerve block, at the level of the adductor canal (study technique).
The block will be under ultrasound guidance.
The local anesthetic will be 15 ml of 0.5% bupivacaine.
All study patients, regardless of study arm will receive combined spinal epidural, with 3 ml of 0.5% bupivacaine as the spinal agent.
Epidural local anesthetic, if needed, will consist of 2% lidocaine.
The other leg will receive the femoral nerve block (control technique).
The block will be under ultrasound guidance.
The local anesthetic will be 30 ml of 0.25% bupivacaine.
All study patients, regardless of study arm will receive combined spinal epidural, with 3 ml of 0.5% bupivacaine as the spinal agent.
Epidural local anesthetic, if needed, will consist of 2% lidocaine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale Pain Score
Time Frame: Up to postoperative day 1
|
The primary outcome is the postoperative pain in each leg within the first 24 hours postoperatively.
VAS pain scores could range from 0 to 10. Higher values represent a worse outcome.
|
Up to postoperative day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tracking Total Opioid Usage
Time Frame: Up to postoperative day 2
|
Up to postoperative day 2
|
|
|
Preoperative and Postoperative Thigh Muscle Strength in Both Legs
Time Frame: Up to postoperative day 2
|
This was measured with a dynamometer to gauge strength.
|
Up to postoperative day 2
|
|
Patient Satisfaction With Nerve Blocks
Time Frame: Up to postoperative day 1
|
Rated on a 0-10 scale, with a higher score representing greater satisfaction.
|
Up to postoperative day 1
|
|
Duration of Motor and Sensory Blockade
Time Frame: Up to postoperative day 2
|
Up to postoperative day 2
|
|
|
Rating the Success of the Nerve Blocks
Time Frame: Up to postoperative day 2
|
Up to postoperative day 2
|
|
|
Postoperative Complications
Time Frame: Up to postoperative day 2
|
Up to postoperative day 2
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Akkaya T, Ersan O, Ozkan D, Sahiner Y, Akin M, Gumus H, Ates Y. Saphenous nerve block is an effective regional technique for post-menisectomy pain. Knee Surg Sports Traumatol Arthrosc. 2008 Sep;16(9):855-8. doi: 10.1007/s00167-008-0572-4. Epub 2008 Jun 24.
- Horn JL, Pitsch T, Salinas F, Benninger B. Anatomic basis to the ultrasound-guided approach for saphenous nerve blockade. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):486-9. doi: 10.1097/AAP.0b013e3181ae11af.
- Manickam B, Perlas A, Duggan E, Brull R, Chan VW, Ramlogan R. Feasibility and efficacy of ultrasound-guided block of the saphenous nerve in the adductor canal. Reg Anesth Pain Med. 2009 Nov-Dec;34(6):578-80. doi: 10.1097/aap.0b013e3181bfbf84.
- Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. doi: 10.1097/00000542-199907000-00006.
- Singelyn FJ, Ferrant T, Malisse MF, Joris D. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous femoral nerve sheath block on rehabilitation after unilateral total-hip arthroplasty. Reg Anesth Pain Med. 2005 Sep-Oct;30(5):452-7. doi: 10.1016/j.rapm.2005.05.008.
- Kandasami M, Kinninmonth AW, Sarungi M, Baines J, Scott NB. Femoral nerve block for total knee replacement - a word of caution. Knee. 2009 Mar;16(2):98-100. doi: 10.1016/j.knee.2008.10.007. Epub 2008 Nov 28.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2012-033
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Difference Between Femoral Nerve Block and Saphenous Block
-
University of British ColumbiaCompleted
-
Ain Shams UniversityCompletedHip Hemiarthroplasty | Pericapsular Nerve Group Block | Lateral Femoral Cutaneous Nerve Block | Supra-inguinal Fascia Iliaca BlockEgypt
-
Kafrelsheikh UniversityRecruitingAnalgesia | Lateral Femoral Cutaneous Nerve Block | Vastus Lateralis Nerve Block | Knee SurgeriesEgypt
-
Mogilev Regional Clinical HospitalCompletedUltrasonography | Nerve Block | Efficiency | Femoral NerveBelarus
-
Philipps University Marburg Medical CenterCompletedTotal Knee Arthroplasty | Total Knee Replacement | Adductor Canal Block | Femoral Nerve BlockGermany
-
Cork University HospitalCompletedBimalleolar Fractures of the Ankle. | Sciatic Nerve Block. | Saphenous Nerve Block. | Post Operative Analgesia Duration.Ireland
-
National Cancer Institute, EgyptRecruitingFemoral Nerve Block | Amputation of KneeEgypt
-
Cairo UniversityCompletedDexmedetomidine | Arthroscopic Knee Surgery | Femoral Nerve BlockEgypt
-
Ain Shams UniversityRecruitingAnlgesia for Hip Arthroscopy by Assessing Quality of Different Type of Regional Block, Femoral Nerve Block Versus Fascia Iliaca BlockEgypt
-
Mogilev Regional Clinical HospitalRecruitingUltrasonography | Nerve Block | Efficiency | Femoral Nerve | Minimum Effective DoseBelarus
Clinical Trials on Study Technique
-
University Hospital, Basel, SwitzerlandNot yet recruiting
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | ThromboembolismUnited States
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); SWOG Cancer Research NetworkCompletedLung CancerUnited States
-
Providence Medical Technology, Inc.RecruitingRadiculopathy Lumbar | Degenerative Lumbar Disc DiseaseUnited States
-
Hospices Civils de LyonCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Solid Tumor
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMelanoma (Skin)
-
Cytheris SACytheris, Inc.TerminatedKidney Cancer | Melanoma (Skin)United States
-
NCIC Clinical Trials GroupS*BIOCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada